CG
ARKG icon

Cutler Group’s ARK Genomic Revolution ETF ARKG Stock Holding History

Cutler Group’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$45K Sell
22,000
-18,400
-46% -$553K 0.01% 717
2023
Q4 		$54K Buy
40,400
+1,100
+3% +$29.9K ﹤0.01% 1400
2023
Q3 		$202K Buy
39,300
+35,600
+962% +$1.16M 0.02% 750
2023
Q2 		$15K Buy
3,700
+600
+19% +$18.9K ﹤0.01% 1992
2023
Q1 		$25K Sell
3,100
-12,500
-80% -$387K ﹤0.01% 1778
2022
Q4 		$181K Sell
15,600
-19,000
-55% -$603K 0.02% 838
2022
Q3 		$479K Sell
34,600
-100,200
-74% -$3.68M 0.03% 542
2022
Q2 		$2.21M Sell
134,800
-12,600
-9% -$441K 0.15% 154
2022
Q1 		$2.64M Sell
147,400
-22,600
-13% -$1.08M 0.14% 157
2021
Q4 		$453K Sell
170,000
-9,500
-5% -$657K 0.02% 798
2021
Q3 		$2.31M Sell
179,500
-258,100
-59% -$21.7M 0.1% 215
2021
Q2 		$1.57M Buy
437,600
+24,400
+6% +$2.07M 0.07% 298
2021
Q1 		$3.27M Buy
413,200
+386,600
+1,453% +$38.3M 0.16% 128
2020
Q4 		$460K Buy
26,600
+24,400
+1,109% +$1.94M 0.02% 671
2020
Q3 		$3K Buy
+2,200
New +$129K ﹤0.01% 3775

Other funds holding ARKG

MMEA
Main Management ETF Advisors San Francisco, California $2.68B AUM 24.27% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

Cutler Group's ARKG Position: Q1 2024 in Review

Cutler Group reduced its ARK Genomic Revolution ETF (ARKG) stake by 73% in Q1 2024, selling an estimated $310K and leaving 3,899 shares worth $112K. The position accounts for 0.04% of the portfolio, ranked #419.

Cutler Group first reported a position in ARKG in Q3 2020 and has held it in 14 quarters since. The position peaked at $712K in Q1 2022. 284 funds tracked by Wall St. Rank hold ARKG as of Q1 2024.

  • Cutler Group held 3,899 shares of ARK Genomic Revolution ETF worth $112K as of Q1 2024.
  • Cutler Group sold 10,304 ARK Genomic Revolution ETF shares in Q1 2024, an estimated $310K.
  • ARK Genomic Revolution ETF made up 0.04% of Cutler Group's portfolio in Q1 2024, its #419 holding.
  • Cutler Group first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 14 quarters since.
  • Cutler Group's ARK Genomic Revolution ETF position peaked at $712K in Q1 2022.
  • 284 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2024.

Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.